Bristol Myers Squibb tops quarterly estimates, hik... CNBC

Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffs

Source: CNBC | Published: April 24, 2025, 11:01 a.m.

The guidance revisions include the estimated impact of current tariffs on U.S. products shipped to China, but not Trump's planned pharmaceutical tariffs.
Read Original Article Back to News List